STOCK TITAN

Nuwellis (NASDAQ: NUWE) director receives 6,744 stock options grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Nuwellis, Inc. director Emerson J. Martin received a grant of nonstatutory stock options as part of his equity compensation. The award covers 6,744 options to buy Nuwellis common stock at an exercise price of $1.16 per share.

The options vest in 12 approximately equal monthly installments starting one month after the grant date, so they are fully vested after one year. The options expire on April 27, 2036 if not exercised. After this grant, Martin holds 6,744 derivative securities related to Nuwellis common stock directly.

Positive

  • None.

Negative

  • None.
Insider Emerson Martin J
Role null
Type Security Shares Price Value
Grant/Award Nonstatutory Stock Option (right to buy) 6,744 $0.00 --
Holdings After Transaction: Nonstatutory Stock Option (right to buy) — 6,744 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Options granted 6,744 options Nonstatutory stock option award to director
Exercise price $1.16 per share Exercise price for Nuwellis common stock under options
Total derivative holdings after grant 6,744 options Total options held by Emerson J. Martin after transaction
Expiration date April 27, 2036 Option term end date if not exercised
Vesting schedule 12 monthly installments over 1 year Vests starting one month after grant date
Nonstatutory Stock Option financial
"Nonstatutory Stock Option (right to buy)"
A nonstatutory stock option (also called a non-qualified stock option) is an employee or contractor right to buy company shares at a set price that does not qualify for special tax treatment. When exercised, the difference between the market price and the set price is treated as ordinary income for the recipient and usually triggers payroll tax and withholding. For investors, these options matter because they create potential share dilution, affect reported compensation costs, and influence the timing of when new shares enter the market—similar to a coupon that lets someone buy stock at a discount but results in an immediate tax bill.
exercise price financial
"conversion_or_exercise_price: "1.1600""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2036-04-27T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
vesting financial
"Vests in 12 approximately equal consecutive monthly increments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Emerson Martin J

(Last)(First)(Middle)
12988 VALLEY VIEW ROAD

(Street)
EDEN PRAIRIE MINNESOTA 55344

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Nuwellis, Inc. [ NUWE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/28/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Nonstatutory Stock Option (right to buy)$1.1604/28/2026A6,744 (1)04/27/2036Common Stock6,744$06,744D
Explanation of Responses:
1. Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the options will be vested on the one-year anniversary of the date of grant.
/s/ Neil P. Ayotte, by Power of Attorney04/29/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Nuwellis (NUWE) disclose in this Form 4 filing?

Nuwellis disclosed that director Emerson J. Martin received a grant of 6,744 nonstatutory stock options. These options allow him to buy Nuwellis common stock at $1.16 per share under a compensation award that vests over one year and expires in April 2036.

How many stock options were granted to Emerson J. Martin at Nuwellis (NUWE)?

Emerson J. Martin was granted 6,744 nonstatutory stock options. Each option represents the right to purchase one share of Nuwellis common stock, subject to vesting conditions and an exercise price of $1.16 per share as disclosed in the Form 4 filing.

What is the exercise price of the new Nuwellis (NUWE) stock options?

The exercise price of the newly granted Nuwellis stock options is $1.16 per share. This means Martin can buy Nuwellis common stock at $1.16 for each of the 6,744 options once they vest and before they expire in April 2036.

When do Emerson J. Martin’s Nuwellis (NUWE) stock options vest?

The options vest in 12 approximately equal monthly installments starting one month after the grant date. According to the footnote, all 6,744 options will be fully vested on the one-year anniversary of the grant, assuming continued eligibility during the vesting period.

What is the expiration date of the Nuwellis (NUWE) stock options granted to Emerson J. Martin?

The nonstatutory stock options granted to Emerson J. Martin expire on April 27, 2036. He must exercise any vested options before that expiration date; otherwise, the right to purchase Nuwellis common stock under those options will lapse.

How many Nuwellis (NUWE) derivative securities does Emerson J. Martin hold after this transaction?

Following this grant, Martin holds 6,744 derivative securities related to Nuwellis common stock. These represent the nonstatutory stock options reported in the filing, all held directly, with each option potentially convertible into one share upon exercise at $1.16.